These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28129978)

  • 1. Synthesis and biological evaluation of 2-alkoxycarbonylallyl esters as potential anticancer agents.
    Ronayne CT; Solano LN; Nelson GL; Lueth EA; Hubbard SL; Schumacher TJ; Gardner ZS; Jonnalagadda SK; Gurrapu S; Holy J; Mereddy VR
    Bioorg Med Chem Lett; 2017 Feb; 27(4):776-780. PubMed ID: 28129978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, in vitro, and in vivo evaluation of novel functionalized quaternary ammonium curcuminoids as potential anti-cancer agents.
    Solano LN; Nelson GL; Ronayne CT; Lueth EA; Foxley MA; Jonnalagadda SK; Gurrapu S; Mereddy VR
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5777-80. PubMed ID: 26561365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel 2-alkoxycarbonylallylester phosphonium derivatives as potential anticancer agents.
    Gardner ZS; Schumacher TJ; Ronayne CT; Kumpati GP; Williams MJ; Yoshimura A; Palle H; Mani C; Rumbley J; Mereddy VR
    Bioorg Med Chem Lett; 2021 Aug; 45():128136. PubMed ID: 34044122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indole carboxylic acid esters of melampomagnolide B are potent anticancer agents against both hematological and solid tumor cells.
    Bommagani S; Ponder J; Penthala NR; Janganati V; Jordan CT; Borrelli MJ; Crooks PA
    Eur J Med Chem; 2017 Aug; 136():393-405. PubMed ID: 28525840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of the vitamin E amino acid esters with an enhanced anticancer activity and in silico screening for new antineoplastic drugs.
    Gagic Z; Ivkovic B; Srdic-Rajic T; Vucicevic J; Nikolic K; Agbaba D
    Eur J Pharm Sci; 2016 Jun; 88():59-69. PubMed ID: 27063330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.
    Zhou Q; Ji M; Zhou J; Jin J; Xue N; Chen J; Xu B; Chen X
    Biochem Pharmacol; 2016 May; 107():29-40. PubMed ID: 26920250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapy.
    Chen W; Guo N; Qi M; Dai H; Hong M; Guan L; Huan X; Song S; He J; Wang Y; Xi Y; Yang X; Shen Y; Su Y; Sun Y; Gao Y; Chen Y; Ding J; Tang Y; Ren G; Miao Z; Li J
    Eur J Med Chem; 2017 Sep; 138():514-531. PubMed ID: 28692916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin carboxylic acids as monocarboxylate transporter 1 inhibitors: In vitro and in vivo studies as potential anticancer agents.
    Gurrapu S; Jonnalagadda SK; Alam MA; Ronayne CT; Nelson GL; Solano LN; Lueth EA; Drewes LR; Mereddy VR
    Bioorg Med Chem Lett; 2016 Jul; 26(14):3282-3286. PubMed ID: 27241692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents.
    Solano LN; Nelson GL; Ronayne CT; Jonnalagadda S; Jonnalagadda SK; Kottke K; Chitren R; Johnson JL; Pandey MK; Jonnalagadda SC; Mereddy VR
    Sci Rep; 2020 Oct; 10(1):17969. PubMed ID: 33087745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and in vitro anticancer evaluation of a stearic acid-based ester conjugate.
    Khan AA; Alanazi AM; Jabeen M; Chauhan A; Abdelhameed AS
    Anticancer Res; 2013 Jun; 33(6):2517-24. PubMed ID: 23749903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization, pharmacophore modeling and 3D-QSAR studies of sipholanes as breast cancer migration and proliferation inhibitors.
    Foudah AI; Sallam AA; Akl MR; El Sayed KA
    Eur J Med Chem; 2014 Feb; 73():310-24. PubMed ID: 24487236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer therapeutic potential of Mn porphyrin/ascorbate system.
    Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I
    Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of new 2-galactosylthiazolidine-4-carboxylic acid amides. Antitumor evaluation against melanoma and breast cancer cells.
    Serra AC; Rocha Gonsalves AM; Laranjo M; Abrantes AM; Gonçalves AC; Sarmento-Ribeiro AB; Botelho MF
    Eur J Med Chem; 2012 Jul; 53():398-402. PubMed ID: 22560315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of benzofuran- and 2,3-dihydrobenzofuran-2-carboxylic acid N-(substituted)phenylamide derivatives as anticancer agents and inhibitors of NF-κB.
    Choi M; Jo H; Park HJ; Sateesh Kumar A; Lee J; Yun J; Kim Y; Han SB; Jung JK; Cho J; Lee K; Kwak JH; Lee H
    Bioorg Med Chem Lett; 2015 Jun; 25(12):2545-9. PubMed ID: 25953156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and antitumor evaluation of novel acenaphtho[1,2-b]pyrrole-carboxylic acid esters with amino chain substitution.
    Liu F; Qian X; Cui J; Xiao Y; Zhang R; Li G
    Bioorg Med Chem; 2006 Jul; 14(13):4639-44. PubMed ID: 16516477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
    Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH
    Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semisynthetic Esters of 17-Hydroxycativic Acid with in Vitro Cytotoxic Activity against Leukemia Cell Lines.
    Cavallaro V; Řezníčková E; Jorda R; Alza NP; Murray AP; Kryštof V
    Biol Pharm Bull; 2017; 40(11):1923-1928. PubMed ID: 29093339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials.
    Yuan B; Ye N; Song SS; Wang YT; Song Z; Chen HD; Chen CH; Huan XJ; Wang YQ; Su Y; Shen YY; Sun YM; Yang XY; Chen Y; Guo SY; Gan Y; Gao ZW; Chen XY; Ding J; He JX; Zhang A; Miao ZH
    Cancer Lett; 2017 Feb; 386():47-56. PubMed ID: 27847302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl)benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo.
    Shi DF; Bradshaw TD; Wrigley S; McCall CJ; Lelieveld P; Fichtner I; Stevens MF
    J Med Chem; 1996 Aug; 39(17):3375-84. PubMed ID: 8765521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53.
    Ronayne CT; Jonnalagadda SK; Jonnalagadda S; Nelson GL; Solano LN; Palle H; Mani C; Rumbley J; Holy J; Mereddy VR
    Biochem Biophys Res Commun; 2021 Jul; 562():127-132. PubMed ID: 34051576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.